Stefanie Kiderlen

Stefanie Kiderlen

Auto-generated profile, based on publicly available information

Stefanie Kiderlen

Prospective Instruments Dornbirn 6850 Austria

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2021 in Nature Materials
Verified
Journal Article
Closed access
PDF file
RRRaphael Reuten
Raphael Reuten
SZSina Zendehroud
Sina Zendehroud
MNMonica Nicolau
Monica Nicolau
LFLutz Fleischhauer
Lutz Fleischhauer
ALAnu Laitala
Anu Laitala
JEJanine Terra Erler
Janine Terra Erler

1 February 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
SKStefanie Kiderlen
Stefanie Kiderlen
CPChristoph Polzer
Christoph Polzer
JRJoachim O. Rädler
Joachim O. Rädler
Denitsa DochevaDenitsa Docheva
Denitsa Docheva
HCHauke Clausen-Schaumann
Hauke Clausen-Schaumann
SSStefanie Sudhop
Stefanie Sudhop
Tendon stem/progenitor cells (TSPC) are potential targets for regenerative medicine and the treatment of tendon injuries. The frequency of such injuries increases in elderly patients while the proportion of functional TSPCs in tendon tissue decreases, protracting tendon repair. Using atomic force microscopy (AFM), we show that cell stiffness and size increase in TSPCs isolated from elderly patients (A-TSPC) compared to TSPCs from younger patients (Y-TSPC). Additionally, two-photon excited fluorescence (TPEF) microscopy revealed a denser, well-structured actin cytoskeleton in A-TSPC, which correlates with the augmented cell stiffness. Treating A-TSPC with ROCK-inhibitor, reverses these age-related changes, and has rejuvenating effect on cell morphology and stiffness. We assume that cellular stiffness is a suitable marker for cell aging and ROCK a potential target for therapeutic applications of cell rejuvenation.

15 April 2024 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
MWMatthias Guido Wiesli
Matthias Guido Wiesli
MHMatthias Werner Huber
Matthias Werner Huber
BWBernhard Weisse
Bernhard Weisse
RZRobert Zboray
Robert Zboray
SKStefanie Kiderlen
Stefanie Kiderlen
WLWilliam Arthur Lackington
William Arthur Lackington
Following biomaterial implantation, a failure to resolve inflammation during the formation of a fracture hematoma can significantly limit the biomaterial's ability to facilitate bone regeneration. This study aims to combine the immunomodulatory and osteogenic effects of BMP‐7 and IL‐10 with the regenerative capacity of collagen‐hydroxyapatite (CHA) scaffolds to enhance in vitro mineralization in a hematoma‐like environment. Incubation of CHA scaffolds with human whole blood leads to rapid adsorption of fibrinogen, significant stiffening of the scaffold, and the formation of a hematoma‐like environment characterized by a limited capacity to support the infiltration of human bone progenitor cells, a significant upregulation of inflammatory cytokines and acute phase proteins, and significantly reduced osteoconductivity. CHA scaffolds functionalized with BMP‐7 and IL‐10 significantly downregulate the production of key inflammatory cytokines, including IL‐6, IL‐8, and leptin, creating a more permissive environment for mineralization, ultimately enhancing the biomaterial's osteoconductivity. In conclusion, targeting the onset of inflammation in the early phase of bone healing using BMP‐7 and IL‐10 functionalized CHA scaffolds is a promising approach to effectively downregulate inflammatory processes, while fostering a more permissive environment for bone regeneration.

22 June 2023 in BIOspektrum
Verified
Journal Article
Closed access
PDF file
DRDaniel Rüdiger
Daniel Rüdiger
SKStefanie Kiderlen
Stefanie Kiderlen
KLKim Whye Leong
Kim Whye Leong
ENElfriede Nössner
Elfriede Nössner
MGMarisa Götzfried
Marisa Götzfried